NELARABINE

NELARABINE was reported 974 times

NELARABINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DRUG METABOLITE LEVEL 1 0.5000
1 PRECURSOR T-LYMPHOBLASTIC LEUKAEMIA ACUTE 1 0.2500
2 FIBRINOUS BRONCHITIS 14 0.1842
3 T-CELL TYPE ACUTE LEUKAEMIA 21 0.1029
4 VARICELLA ZOSTER SEPSIS 1 0.0714
5 PRIMARY BREAST LYMPHOMA 1 0.0625
6 LARYNGEAL NERVE DYSFUNCTION 1 0.0588
7 OCULAR CANCER METASTATIC 1 0.0556
8 NON-HODGKIN'S LYMPHOMA STAGE III 1 0.0435
9 BLAST CELLS 2 0.0385
10 NECROTISING GASTRITIS 1 0.0312
11 INFLAMMATORY MYOFIBROBLASTIC TUMOUR 4 0.0308
12 CHEMICAL EYE INJURY 3 0.0306
13 CSF RED BLOOD CELL COUNT POSITIVE 1 0.0286
14 MYELOPATHY 52 0.0274
15 PERIPHERAL MOTOR NEUROPATHY 37 0.0264
16 ANTITHROMBIN III DECREASED 7 0.0256
17 ISCHAEMIC GASTRITIS 1 0.0256
18 ASPERGILLUS TEST 1 0.0256
19 LEUKAEMIC INFILTRATION BRAIN 1 0.0250
20 SCEDOSPORIUM INFECTION 17 0.0241
21 SUBACUTE COMBINED CORD DEGENERATION 4 0.0229
22 VIBRATION SYNDROME 1 0.0217
23 PROSTATITIS ESCHERICHIA COLI 1 0.0200
24 PSEUDOMONAL BACTERAEMIA 16 0.0187
25 NERVE CONDUCTION STUDIES ABNORMAL 3 0.0180
26 BLAST CELL PROLIFERATION 1 0.0175
27 POLYOMAVIRUS TEST POSITIVE 2 0.0169
28 SOMATOSENSORY EVOKED POTENTIALS ABNORMAL 1 0.0167
29 HYPOGLOSSAL NERVE PARALYSIS 1 0.0156
30 LOSS OF PROPRIOCEPTION 5 0.0155
31 TOXIC LEUKOENCEPHALOPATHY 11 0.0152
32 ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY 2 0.0148
33 TONSILLAR ULCER 2 0.0138
34 SPINAL CORD ISCHAEMIA 2 0.0132
35 STENOTROPHOMONAS INFECTION 17 0.0125
36 RESPIRATORY PARALYSIS 2 0.0125
37 LIVER IRON CONCENTRATION INCREASED 1 0.0123
38 BONE MARROW LEUKAEMIC CELL INFILTRATION 1 0.0122
39 DIFFUSE AXONAL INJURY 1 0.0120
40 WEST NILE VIRAL INFECTION 9 0.0120
41 DECREASED VIBRATORY SENSE 4 0.0118
42 AUTOLOGOUS HAEMATOPOIETIC STEM CELL TRANSPLANT 1 0.0112
43 CENTRAL NERVOUS SYSTEM NECROSIS 3 0.0109
44 HEPATOSPLENIC T-CELL LYMPHOMA 4 0.0108
45 ACUTE BIPHENOTYPIC LEUKAEMIA 1 0.0108
46 T-CELL PROLYMPHOCYTIC LEUKAEMIA 1 0.0108
47 CEREBRAL SALT-WASTING SYNDROME 1 0.0101
48 PERIPHERAL SENSORY NEUROPATHY 56 0.0096
49 MALIGNANT MEDIASTINAL NEOPLASM 1 0.0091
50 PANCREATIC LEAK 1 0.0089
51 GUILLAIN-BARRE SYNDROME 42 0.0087
52 SPINAL CORD DISORDER 14 0.0085
53 BONE MARROW TUMOUR CELL INFILTRATION 1 0.0085
54 RESIDUAL URINE 1 0.0084
55 MINIMAL RESIDUAL DISEASE 4 0.0083
56 ANAESTHESIA 3 0.0082
57 MAGNETIC RESONANCE IMAGING SPINAL ABNORMAL 1 0.0082
58 INFECTIVE ANEURYSM 4 0.0081
59 SUPERIOR VENA CAVAL OCCLUSION 1 0.0079
60 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 11 0.0078
61 CYTOTOXIC OEDEMA 2 0.0075
62 HYPERTROPHY 4 0.0074
63 MENINGITIS STAPHYLOCOCCAL 1 0.0070
64 BLADDER DYSFUNCTION 7 0.0068
65 PSOAS ABSCESS 4 0.0064
66 DIAPHRAGM MUSCLE WEAKNESS 1 0.0063
67 ACID FAST BACILLI INFECTION 1 0.0062
68 EPSTEIN BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER 3 0.0061
69 BLAST CELL CRISIS 2 0.0060
70 RADICULITIS 1 0.0060
71 DIASTOLIC HYPOTENSION 1 0.0059
72 SEPTIC ARTHRITIS STAPHYLOCOCCAL 2 0.0057
73 CRANIAL NERVE DISORDER 4 0.0057
74 MULTIFOCAL MOTOR NEUROPATHY 1 0.0057
75 ACUTE MONOCYTIC LEUKAEMIA 1 0.0055
76 SPINAL CORD OEDEMA 2 0.0054
77 LEUKOENCEPHALOPATHY 20 0.0054
78 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0053
79 CYSTITIS VIRAL 2 0.0052
80 MEDIASTINAL MASS 2 0.0052
81 ANORECTAL DISORDER 10 0.0050
82 PERIPHERAL SENSORIMOTOR NEUROPATHY 6 0.0048
83 REFRACTORY CANCER 1 0.0047
84 MYELITIS 7 0.0045
85 CAECITIS 2 0.0044
86 SENSORY LEVEL ABNORMAL 1 0.0044
87 ALDOLASE INCREASED 1 0.0044
88 SYSTEMIC MYCOSIS 5 0.0043
89 BONE MARROW NECROSIS 1 0.0043
90 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 11 0.0043
91 VIRAL HAEMORRHAGIC CYSTITIS 3 0.0042
92 NEUROGENIC BOWEL 1 0.0042
93 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 3 0.0042
94 LEUKAEMIA RECURRENT 7 0.0041
95 CERVICAL MYELOPATHY 1 0.0041
96 HAEMOPHILUS INFECTION 4 0.0041
97 BRAIN STEM SYNDROME 3 0.0040
98 ANORECTAL INFECTION 1 0.0040
99 PARAPARESIS 7 0.0039
100 HYPERTRIGLYCERIDAEMIA 23 0.0039
101 NON-ALCOHOLIC STEATOHEPATITIS 4 0.0039
102 CENTRAL PAIN SYNDROME 1 0.0038
103 HUMAN POLYOMAVIRUS INFECTION 2 0.0038
104 HYPOREFLEXIA 7 0.0036
105 CSF PROTEIN INCREASED 3 0.0036
106 BULBAR PALSY 1 0.0036
107 PERIVENTRICULAR LEUKOMALACIA 1 0.0035
108 ANDROGENETIC ALOPECIA 1 0.0035
109 MYCOBACTERIUM HAEMOPHILUM INFECTION 1 0.0035
110 ACUTE POLYNEUROPATHY 1 0.0035
111 T-CELL LYMPHOMA 4 0.0035
112 ENGRAFT FAILURE 1 0.0035
113 NEUROTOXICITY 61 0.0035
114 HISTIOCYTOSIS HAEMATOPHAGIC 10 0.0034
115 ASPERGILLUS INFECTION 22 0.0033
116 COAGULATION TIME ABNORMAL 1 0.0033
117 SUPERIOR VENA CAVA SYNDROME 2 0.0033
118 ENTEROCOLITIS VIRAL 1 0.0033
119 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 9 0.0033
120 ABULIA 3 0.0032
121 DEVICE RELATED BACTERAEMIA 1 0.0032
122 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 1 0.0030
123 DIPLEGIA 6 0.0030
124 AREFLEXIA 8 0.0030
125 DEMYELINATING POLYNEUROPATHY 3 0.0029
126 QUADRIPLEGIA 6 0.0029
127 ARACHNOIDITIS 2 0.0029
128 MYELITIS TRANSVERSE 4 0.0028
129 ACUTE LYMPHOCYTIC LEUKAEMIA 8 0.0028
130 PARAPLEGIA 8 0.0028
131 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 1 0.0028
132 GASTRIC MUCOSAL LESION 2 0.0027
133 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0027
134 MEDIASTINAL DISORDER 1 0.0027
135 RADICULOPATHY 7 0.0027
136 FOLATE DEFICIENCY 3 0.0026
137 TOXIC NEUROPATHY 1 0.0025
138 MAGNETIC RESONANCE IMAGING ABNORMAL 3 0.0025
139 SPINAL CORD HAEMORRHAGE 1 0.0025
140 TRICHOSPORON INFECTION 1 0.0025
141 LYMPHOCYTIC LEUKAEMIA 1 0.0025
142 TUMOUR ASSOCIATED FEVER 1 0.0024
143 SPHINCTER OF ODDI DYSFUNCTION 1 0.0024
144 METASTASES TO SPLEEN 1 0.0024
145 CHLOROMA 1 0.0024
146 SENSORY LOSS 19 0.0024
147 GLIOSIS 1 0.0023
148 ANAL SPHINCTER ATONY 1 0.0023
149 PULMONARY HAEMORRHAGE 18 0.0023
150 SPINAL CORD INJURY 4 0.0023
151 GRAFT VERSUS HOST DISEASE IN SKIN 5 0.0023
152 THERAPEUTIC PRODUCT EFFECT PROLONGED 1 0.0022
153 VENTRICULAR ARRHYTHMIA 8 0.0022
154 EPIDERMOLYSIS 1 0.0022
155 MANUFACTURING ISSUE 1 0.0022
156 MENINGISM 1 0.0021
157 POLYNEUROPATHY 25 0.0021
158 BK VIRUS INFECTION 7 0.0021
159 HYPOFIBRINOGENAEMIA 2 0.0020
160 VENOOCCLUSIVE DISEASE 5 0.0020
161 COMPLICATIONS OF TRANSPLANT SURGERY 1 0.0020
162 AUTONOMIC NEUROPATHY 2 0.0020
163 DYSAESTHESIA 6 0.0020
164 CHRONIC GRAFT VERSUS HOST DISEASE 7 0.0019
165 ATAXIA 23 0.0019
166 BRONCHOPULMONARY ASPERGILLOSIS 15 0.0019
167 NEUTROPENIC COLITIS 4 0.0019
168 TRANSVERSE SINUS THROMBOSIS 1 0.0019
169 NEUROGENIC BLADDER 4 0.0019
170 PNEUMOCYSTIS JIROVECII PNEUMONIA 19 0.0019
171 DISINHIBITION 3 0.0019
172 SEROSITIS 1 0.0018
173 EPSTEIN-BARR VIRAEMIA 2 0.0018
174 B-CELL LYMPHOMA 6 0.0018
175 CYSTITIS HAEMORRHAGIC 7 0.0017
176 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 3 0.0017
177 ENGRAFTMENT SYNDROME 1 0.0017
178 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 1 0.0017
179 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
180 VOCAL CORD PARALYSIS 3 0.0017
181 ENCEPHALITIS VIRAL 2 0.0016
182 BRONCHIECTASIS 11 0.0016
183 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
184 CYTOMEGALOVIRUS INFECTION REACTIVATION 7 0.0016
185 INTESTINAL FUNCTIONAL DISORDER 1 0.0016
186 NON-HODGKIN'S LYMPHOMA 2 0.0015
187 GASTROINTESTINAL MUCOSAL DISORDER 1 0.0015
188 ABSCESS NECK 1 0.0015
189 DEMYELINATION 6 0.0015
190 CYTOKINE STORM 1 0.0015
191 CENTRAL NERVOUS SYSTEM LYMPHOMA 2 0.0015
192 ATRIAL THROMBOSIS 3 0.0014
193 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 1 0.0014
194 VENOOCCLUSIVE LIVER DISEASE 7 0.0014
195 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
196 LARYNGEAL DISORDER 1 0.0014
197 OSMOTIC DEMYELINATION SYNDROME 1 0.0014
198 APRAXIA 2 0.0013
199 PARESIS 3 0.0013
200 STEROID DIABETES 2 0.0013
201 ACUTE GRAFT VERSUS HOST DISEASE 6 0.0013
202 CAUDA EQUINA SYNDROME 1 0.0013
203 COAGULATION TEST ABNORMAL 1 0.0013
204 PANCREATIC PSEUDOCYST 1 0.0013
205 PULMONARY MYCOSIS 1 0.0013
206 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 1 0.0013
207 ESCHERICHIA BACTERAEMIA 3 0.0013
208 CROUP INFECTIOUS 1 0.0013
209 BACTERIAL SEPSIS 4 0.0012
210 ILLUSION 2 0.0012
211 STEM CELL TRANSPLANT 3 0.0012
212 HEPATITIS A 1 0.0012
213 BACTERAEMIA 14 0.0012
214 HEPATOSPLENOMEGALY 3 0.0012
215 HYPERBILIRUBINAEMIA 12 0.0012
216 FUNCTIONAL GASTROINTESTINAL DISORDER 4 0.0012
217 AXONAL NEUROPATHY 1 0.0011
218 FEBRILE NEUTROPENIA 76 0.0011
219 BONE MARROW FAILURE 23 0.0011
220 CYTOMEGALOVIRUS TEST POSITIVE 2 0.0011
221 CARDIOTOXICITY 10 0.0011
222 MONOPARESIS 2 0.0011
223 CEREBRAL VENOUS THROMBOSIS 2 0.0011
224 HYPOMANIA 4 0.0011
225 EXTENSOR PLANTAR RESPONSE 1 0.0011
226 SECOND PRIMARY MALIGNANCY 9 0.0011
227 TONGUE INJURY 1 0.0011
228 MICROANGIOPATHY 1 0.0011
229 HUMAN HERPESVIRUS 6 INFECTION 2 0.0011
230 HYPOPROTEINAEMIA 2 0.0011
231 MYOPATHY 9 0.0010
232 ONCOLOGIC COMPLICATION 1 0.0010
233 MALNUTRITION 11 0.0010
234 ENCEPHALOPATHY 24 0.0010
235 GRAFT VERSUS HOST DISEASE 7 0.0010
236 BLAST CELL COUNT INCREASED 1 0.0010
237 METASTASES TO PLEURA 1 0.0010
238 ENTEROCOCCAL BACTERAEMIA 1 0.0009
239 POLYOMAVIRUS VIRAEMIA 1 0.0009
240 IRON OVERLOAD 1 0.0009
241 MONOPLEGIA 4 0.0009
242 HYPOGAMMAGLOBULINAEMIA 6 0.0009
243 BLADDER DISORDER 9 0.0009
244 METASTASES TO MENINGES 2 0.0009
245 NEUROLOGICAL SYMPTOM 5 0.0009
246 RHINITIS 7 0.0009
247 HYPERREFLEXIA 3 0.0009
248 RECTAL ULCER 1 0.0009
249 PROTHROMBIN TIME PROLONGED 5 0.0008
250 ESCHERICHIA TEST POSITIVE 1 0.0008
251 UPPER RESPIRATORY TRACT INFLAMMATION 1 0.0008
252 PSEUDOMONAS INFECTION 7 0.0008
253 SENSORY DISTURBANCE 13 0.0008
254 INFLAMMATORY MARKER INCREASED 4 0.0008
255 OSTEITIS 2 0.0008
256 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 4 0.0008
257 NECROTISING COLITIS 1 0.0008
258 APPENDICITIS PERFORATED 2 0.0008
259 AMMONIA INCREASED 4 0.0008
260 LIPASE INCREASED 6 0.0008
261 ABDOMINAL INFECTION 2 0.0008
262 ADJUSTMENT DISORDER 1 0.0008
263 RETINAL DEGENERATION 1 0.0008
264 THERAPY PARTIAL RESPONDER 12 0.0008
265 PNEUMONIA FUNGAL 3 0.0008
266 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 1 0.0008
267 CYTOPENIA 9 0.0007
268 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 7 0.0007
269 MUCOUS MEMBRANE DISORDER 1 0.0007
270 SUBDURAL HAEMORRHAGE 2 0.0007
271 VIRAEMIA 1 0.0007
272 RHABDOMYOLYSIS 30 0.0007
273 NECROSIS 4 0.0007
274 NERVOUS SYSTEM DISORDER 22 0.0007
275 POST HERPETIC NEURALGIA 1 0.0007
276 NOROVIRUS INFECTION 1 0.0007
277 SEPTIC SHOCK 30 0.0007
278 MUTISM 1 0.0007
279 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 1 0.0007
280 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
281 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
282 NODAL RHYTHM 1 0.0007
283 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
284 PITUITARY TUMOUR 1 0.0007
285 NEUROPATHY PERIPHERAL 63 0.0007
286 BONE MARROW DISORDER 2 0.0007
287 DYSCHEZIA 2 0.0007
288 NEOPLASM SKIN 1 0.0006
289 PRODUCT DEPOSIT 1 0.0006
290 ONYCHOLYSIS 1 0.0006
291 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
292 LYMPHOPENIA 9 0.0006
293 FUNGAEMIA 1 0.0006
294 BLOOD ALBUMIN DECREASED 5 0.0006
295 SKIN EROSION 2 0.0006
296 ACUTE LEUKAEMIA 1 0.0006
297 RESUSCITATION 1 0.0006
298 NUCLEAR MAGNETIC RESONANCE IMAGING ABNORMAL 2 0.0006
299 QUADRIPARESIS 1 0.0006
300 EMBOLISM 5 0.0006
301 BRAIN INJURY 6 0.0006
302 ENTEROBACTER INFECTION 1 0.0006
303 NEUROPATHY 1 0.0006
304 HEPATOTOXICITY 13 0.0006
305 CHOREA 1 0.0006
306 VIITH NERVE PARALYSIS 2 0.0006
307 PARTIAL SEIZURES 3 0.0006
308 PSEUDOMONAL SEPSIS 1 0.0006
309 SERUM FERRITIN INCREASED 3 0.0006
310 TUMOUR LYSIS SYNDROME 5 0.0006
311 NYSTAGMUS 3 0.0006
312 FACIAL PARESIS 2 0.0006
313 MYOSITIS 5 0.0006
314 HEPATIC CYTOLYSIS 7 0.0005
315 SOFT TISSUE INFECTION 1 0.0005
316 PNEUMONIA KLEBSIELLA 1 0.0005
317 AMYLASE INCREASED 2 0.0005
318 AURA 1 0.0005
319 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
320 MUCOSAL INFLAMMATION 14 0.0005
321 MYELOSUPPRESSION 19 0.0005
322 MECHANICAL VENTILATION 1 0.0005
323 HYPOALBUMINAEMIA 4 0.0005
324 GENE MUTATION 1 0.0005
325 SEPSIS 56 0.0005
326 ADRENAL INSUFFICIENCY 6 0.0005
327 MOTOR DYSFUNCTION 5 0.0005
328 RECURRENT CANCER 2 0.0005
329 MUSCULAR WEAKNESS 55 0.0005
330 EPSTEIN-BARR VIRUS INFECTION 3 0.0005
331 RESPIRATORY FAILURE 35 0.0005
332 HYPERPHOSPHATAEMIA 1 0.0005
333 FACIAL PALSY 1 0.0005
334 ALTERED STATE OF CONSCIOUSNESS 10 0.0005
335 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
336 ASPIRATION 5 0.0005
337 CEREBELLAR SYNDROME 1 0.0005
338 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
339 CYTOKINE RELEASE SYNDROME 9 0.0004
340 ILEUS PARALYTIC 2 0.0004
341 PSEUDOMEMBRANOUS COLITIS 1 0.0004
342 LARGE INTESTINAL HAEMORRHAGE 1 0.0004
343 FEAR OF DEATH 1 0.0004
344 GASTROINTESTINAL HYPOMOTILITY 1 0.0004
345 CHRONIC GASTRITIS 1 0.0004
346 RENAL COLIC 1 0.0004
347 ALANINE AMINOTRANSFERASE INCREASED 27 0.0004
348 DISEASE COMPLICATION 2 0.0004
349 PANCREATITIS NECROTISING 1 0.0004
350 CYTOMEGALOVIRUS COLITIS 1 0.0004
351 EYELID DISORDER 1 0.0004
352 APHTHOUS STOMATITIS 1 0.0004
353 GRAND MAL CONVULSION 4 0.0004
354 ASPARTATE AMINOTRANSFERASE INCREASED 23 0.0004
355 FLAT AFFECT 1 0.0004
356 NEUTROPENIC SEPSIS 3 0.0004
357 PARALYSIS 6 0.0004
358 FAECAL INCONTINENCE 2 0.0004
359 HYPERNATRAEMIA 2 0.0004
360 TACHYARRHYTHMIA 1 0.0004
361 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
362 MUSCLE ATROPHY 5 0.0004
363 PANCYTOPENIA 22 0.0004
364 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2 0.0004
365 NEUTROPHIL COUNT DECREASED 16 0.0004
366 ACIDOSIS 3 0.0004
367 CANCER PAIN 1 0.0004
368 VENTRICULAR EXTRASYSTOLES 4 0.0004
369 ACUTE MYELOID LEUKAEMIA 6 0.0004
370 MUCORMYCOSIS 1 0.0004
371 NEUTROPENIA 52 0.0004
372 PSYCHOMOTOR SKILLS IMPAIRED 1 0.0004
373 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
374 WHITE BLOOD CELL DISORDER 1 0.0004
375 ANAL FISSURE 2 0.0004
376 THROMBOCYTOPENIA 41 0.0004
377 ABASIA 9 0.0004
378 ENTEROCOLITIS 2 0.0003
379 VOMITING PROJECTILE 1 0.0003
380 FINE MOTOR SKILL DYSFUNCTION 1 0.0003
381 ESCHERICHIA SEPSIS 1 0.0003
382 ADENOVIRUS INFECTION 1 0.0003
383 ELECTROLYTE IMBALANCE 4 0.0003
384 GASTROINTESTINAL NECROSIS 1 0.0003
385 MALIGNANT NEOPLASM PROGRESSION 34 0.0003
386 THROMBOPHLEBITIS SUPERFICIAL 1 0.0003
387 EMBOLISM VENOUS 1 0.0003
388 PLATELET COUNT DECREASED 35 0.0003
389 DIASTOLIC DYSFUNCTION 1 0.0003
390 APPENDICITIS 3 0.0003
391 LEUKAEMIA 3 0.0003
392 MULTIPLE ORGAN DYSFUNCTION SYNDROME 9 0.0003
393 BLOOD LACTATE DEHYDROGENASE INCREASED 5 0.0003
394 ORTHOPNOEA 1 0.0003
395 HERPES SIMPLEX 2 0.0003
396 HYPOVENTILATION 1 0.0003
397 WALKING AID USER 2 0.0003
398 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
399 COAGULOPATHY 5 0.0003
400 BLOOD BILIRUBIN INCREASED 8 0.0003
401 HEPATIC FUNCTION ABNORMAL 11 0.0003
402 THERAPY NON-RESPONDER 13 0.0003
403 MICTURITION DISORDER 1 0.0003
404 HYPERTRANSAMINASAEMIA 2 0.0003
405 PLEURAL EFFUSION 17 0.0003
406 BONE LESION 1 0.0003
407 HYPERGLYCAEMIA 10 0.0003
408 AGRANULOCYTOSIS 5 0.0003
409 IMMUNODEFICIENCY 4 0.0003
410 PROTEIN TOTAL DECREASED 1 0.0003
411 CHEMOTHERAPY 1 0.0003
412 HYPOAESTHESIA 39 0.0003
413 DEVICE RELATED INFECTION 4 0.0003
414 PERICARDIAL EFFUSION 6 0.0003
415 OPTIC ISCHAEMIC NEUROPATHY 1 0.0003
416 WHITE BLOOD CELL COUNT DECREASED 28 0.0003
417 SPINAL CORD COMPRESSION 1 0.0003
418 ORAL INFECTION 1 0.0003
419 OESOPHAGEAL CANDIDIASIS 1 0.0003
420 FUNGAL SKIN INFECTION 1 0.0002
421 NEURALGIA 6 0.0002
422 SHOCK HAEMORRHAGIC 2 0.0002
423 HYPERAESTHESIA 2 0.0002
424 EXTRAVASATION 1 0.0002
425 PHARYNGITIS 3 0.0002
426 GENERALISED TONIC-CLONIC SEIZURE 4 0.0002
427 CYTOMEGALOVIRUS INFECTION 4 0.0002
428 DYSSTASIA 7 0.0002
429 PERICARDITIS 4 0.0002
430 FEBRILE BONE MARROW APLASIA 1 0.0002
431 PYELONEPHRITIS 2 0.0002
432 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
433 WHEELCHAIR USER 1 0.0002
434 RHINITIS ALLERGIC 1 0.0002
435 BRAIN NEOPLASM MALIGNANT 1 0.0002
436 URINARY TRACT DISORDER 1 0.0002
437 MOVEMENT DISORDER 7 0.0002
438 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
439 MENTAL STATUS CHANGES 6 0.0002
440 DIALYSIS 3 0.0002
441 DISEASE PROGRESSION 25 0.0002
442 SINUS TACHYCARDIA 3 0.0002
443 CARDIAC TAMPONADE 1 0.0002
444 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
445 GAIT DISTURBANCE 39 0.0002
446 HYPERAMMONAEMIA 1 0.0002
447 KLEBSIELLA INFECTION 1 0.0002
448 TOXIC ENCEPHALOPATHY 1 0.0002
449 EYELID PTOSIS 2 0.0002
450 NEUTROPHIL COUNT INCREASED 2 0.0002
451 CACHEXIA 1 0.0002
452 LYMPHOMA 3 0.0002
453 FOETAL DEATH 1 0.0002
454 RESTLESSNESS 7 0.0002
455 DRUG-INDUCED LIVER INJURY 6 0.0002
456 DYSARTHRIA 7 0.0002
457 BEHAVIOUR DISORDER 1 0.0002
458 COLITIS 7 0.0002
459 OESOPHAGITIS 2 0.0002
460 MELAENA 4 0.0002
461 STOMATITIS 11 0.0002
462 VENTRICULAR FIBRILLATION 2 0.0002
463 PANCREATITIS ACUTE 4 0.0002
464 PERONEAL NERVE PALSY 1 0.0002
465 HERPES VIRUS INFECTION 1 0.0002
466 ANAEMIA 33 0.0002
467 PANCREATITIS 9 0.0002
468 DISEASE RECURRENCE 8 0.0002
469 MYOCLONUS 2 0.0002
470 INFUSION RELATED REACTION 11 0.0002
471 LEUKOCYTOSIS 3 0.0002
472 PLATELET COUNT ABNORMAL 1 0.0002
473 SMALL INTESTINAL OBSTRUCTION 2 0.0002
474 OLIGURIA 1 0.0002
475 PARAESTHESIA 25 0.0002
476 HYPOCALCAEMIA 3 0.0002
477 LIVER DISORDER 7 0.0002
478 SCREAMING 1 0.0002
479 INCOHERENT 1 0.0002
480 IMMUNE SYSTEM DISORDER 2 0.0002
481 FUNGAL INFECTION 5 0.0001
482 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
483 SEIZURE 17 0.0001
484 DRUG TOXICITY 2 0.0001
485 HAEMOGLOBIN DECREASED 15 0.0001
486 RESPIRATORY ARREST 4 0.0001
487 ENCEPHALITIS 1 0.0001
488 HYPONATRAEMIA 8 0.0001
489 LEUKOPENIA 7 0.0001
490 SUBDURAL HAEMATOMA 2 0.0001
491 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
492 SOMNOLENCE 28 0.0001
493 MYELODYSPLASTIC SYNDROME 2 0.0001
494 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
495 ORAL DISORDER 1 0.0001
496 PSYCHOTIC DISORDER 4 0.0001
497 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
498 HYPOPHOSPHATAEMIA 1 0.0001
499 URINARY INCONTINENCE 4 0.0001
500 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
501 TRANSAMINASES INCREASED 3 0.0001
502 HYPERTHERMIA 1 0.0001
503 SHOCK 3 0.0001
504 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
505 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
506 APHTHOUS ULCER 1 0.0001
507 LUNG INFECTION 2 0.0001
508 GASTROINTESTINAL INFLAMMATION 1 0.0001
509 ABNORMAL BEHAVIOUR 5 0.0001
510 DECUBITUS ULCER 1 0.0001
511 ASPHYXIA 1 0.0001
512 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
513 SPINAL COMPRESSION FRACTURE 1 0.0001
514 EOSINOPHIL COUNT INCREASED 1 0.0001
515 URINARY RETENTION 4 0.0001
516 COVID-19 21 0.0001
517 GAIT INABILITY 4 0.0001
518 CARDIO-RESPIRATORY ARREST 5 0.0001
519 UPPER GASTROINTESTINAL HAEMORRHAGE 2 0.0001
520 CANDIDA INFECTION 2 0.0001
521 FACIAL PARALYSIS 1 0.0001
522 MULTI-ORGAN FAILURE 2 0.0001
523 HYPERKALAEMIA 4 0.0001
524 HYPOXIA 4 0.0001
525 IMMUNOSUPPRESSION 1 0.0001
526 LUNG INFILTRATION 1 0.0001
527 LYMPHOCYTE COUNT DECREASED 2 0.0001
528 FACIAL PAIN 1 0.0001
529 ANAL INCONTINENCE 1 0.0001
530 PNEUMONITIS 3 0.0001
531 PNEUMONIA BACTERIAL 1 0.0001
532 DYSURIA 4 0.0001
533 HYPOKALAEMIA 5 0.0001
534 HEPATIC STEATOSIS 2 0.0001
535 PYREXIA 37 0.0001
536 OXYGEN SATURATION DECREASED 6 0.0001
537 SPINAL DISORDER 1 0.0001
538 HAEMATOTOXICITY 1 0.0001
539 HYPERSOMNIA 3 0.0001
540 ACUTE KIDNEY INJURY 16 0.0001
541 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
542 HERPES ZOSTER 6 0.0001
543 HYPERCHOLESTEROLAEMIA 1 0.0001
544 SINUS BRADYCARDIA 1 0.0001
545 LIVER FUNCTION TEST ABNORMAL 3 0.0001
546 LUNG DISORDER 5 0.0001
547 LIGAMENT SPRAIN 1 0.0001
548 DISORIENTATION 4 0.0001
549 HAEMATOCRIT DECREASED 2 0.0001
550 APHASIA 3 0.0001
551 SUBARACHNOID HAEMORRHAGE 1 0.0001
552 EPILEPSY 3 0.0001
553 RENAL FAILURE ACUTE 4 0.0001
554 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
555 STAPHYLOCOCCAL INFECTION 3 0.0001
556 GASTROINTESTINAL PAIN 1 0.0001
557 STEVENS-JOHNSON SYNDROME 2 0.0001
558 ORAL PAIN 2 0.0001
559 SKIN INFECTION 1 0.0001
560 CONVULSION 5 0.0001
561 PRODUCT USE IN UNAPPROVED INDICATION 21 0.0001
562 DYSPHAGIA 8 0.0001
563 CEREBRAL HAEMORRHAGE 3 0.0001
564 HYPERLIPIDAEMIA 1 0.0001
565 RENAL IMPAIRMENT 7 0.0001
566 MYALGIA 14 0.0001
567 NO THERAPEUTIC RESPONSE 1 0.0001
568 HYPERCALCAEMIA 1 0.0001
569 ILEUS 1 0.0001
570 HYPOTENSION 16 0.0001
571 HEPATITIS 2 0.0001
572 DRUG RESISTANCE 2 0.0001
573 INFUSION SITE PAIN 1 0.0001
574 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
575 UNRESPONSIVE TO STIMULI 2 0.0001
576 TOXICITY TO VARIOUS AGENTS 13 0.0001
577 PLASMA CELL MYELOMA 3 0.0001
578 SPEECH DISORDER 4 0.0001
579 GASTRITIS 2 0.0001
580 EYE HAEMORRHAGE 1 0.0001
581 FEAR 2 0.0001
582 JAUNDICE 2 0.0001
583 DYSKINESIA 3 0.0001
584 TACHYPNOEA 1 0.0001
585 MOOD ALTERED 2 0.0001
586 ACUTE HEPATIC FAILURE 1 0.0001
587 SKIN LESION 2 0.0001
588 RESPIRATORY DISTRESS 2 0.0001
589 ANAPHYLACTIC REACTION 4 0.0001
590 HYPOMAGNESAEMIA 1 0.0001
591 COORDINATION ABNORMAL 1 0.0001
592 MASS 1 0.0001
593 BLINDNESS UNILATERAL 1 0.0001
594 HEPATOCELLULAR INJURY 1 0.0001
595 RED BLOOD CELL COUNT DECREASED 2 0.0001
596 HYPOACUSIS 3 0.0001
597 PRODUCT USE ISSUE 13 0.0001
598 PULMONARY ARTERIAL HYPERTENSION 1 0.0001
599 ASCITES 2 0.0001
600 TACHYCARDIA 6 0.0001
601 HAEMORRHAGE INTRACRANIAL 1 0.0001
602 RESPIRATORY DISORDER 2 0.0001
603 HEPATIC FAILURE 2 0.0001
604 TREMOR 11 0.0001
605 BLOOD COUNT ABNORMAL 1 0.0001
606 OSTEOPENIA 1 0.0001
607 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
608 VERTIGO 4 0.0001
609 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
610 LIMB DISCOMFORT 2 0.0001
611 MUSCULOSKELETAL CHEST PAIN 1 0.0001
612 EJECTION FRACTION DECREASED 1 0.0001
613 CYANOSIS 1 0.0001
614 COMA 3 0.0001
615 INFECTION 9 0.0001
616 PNEUMONIA 20 0.0001
617 MUSCLE TIGHTNESS 1 0.0001
618 EYE DISORDER 2 0.0001
619 OFF LABEL USE 53 0.0001
620 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
621 BLOOD UREA INCREASED 1 0.0001
622 FACE OEDEMA 1 0.0001
623 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
624 HEMIPARESIS 1 0.0001
625 BALANCE DISORDER 5 0.0001
626 DELIRIUM 2 0.0001
627 NEOPLASM PROGRESSION 2 0.0001
628 ORTHOSTATIC HYPOTENSION 1 0.0001
629 LOCAL SWELLING 1 0.0001
630 METASTASES TO LIVER 1 0.0001
631 LYMPHADENOPATHY 2 0.0001
632 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
633 DECREASED APPETITE 13 0.0001
634 CONFUSIONAL STATE 9 0.0001
635 DRUG EFFECT INCOMPLETE 2 0.0001
636 C-REACTIVE PROTEIN INCREASED 2 0.0001
637 AGITATION 4 0.0001
638 EPISTAXIS 4 0.0001
639 BLISTER 3 0.0001
640 BLOOD URINE PRESENT 1 0.0001
641 GASTRIC ULCER 1 0.0001
642 CHOLESTASIS 1 0.0001
643 ACUTE RESPIRATORY FAILURE 1 0.0001
644 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
645 DYSTONIA 1 0.0001
646 HAEMORRHOIDS 1 0.0001
647 DRUG INEFFECTIVE 67 0.0001
648 ASTHENIA 19 0.0001
649 COUGH 14 0.0000
650 THROMBOSIS 4 0.0000
651 BLINDNESS 2 0.0000
652 BODY TEMPERATURE INCREASED 1 0.0000
653 PERITONITIS 1 0.0000
654 HAEMORRHAGE 5 0.0000
655 HALLUCINATION, VISUAL 1 0.0000
656 ABDOMINAL PAIN 11 0.0000
657 LIVER FUNCTION TEST INCREASED 1 0.0000
658 FAECES DISCOLOURED 1 0.0000
659 CONDITION AGGRAVATED 14 0.0000
660 BLOOD CREATININE INCREASED 3 0.0000
661 PRODUCT PRESCRIBING ISSUE 1 0.0000
662 BLOOD PRESSURE DECREASED 3 0.0000
663 RASH PAPULAR 1 0.0000
664 SNEEZING 1 0.0000
665 PAIN IN EXTREMITY 13 0.0000
666 MUSCLE TWITCHING 1 0.0000
667 OROPHARYNGEAL PAIN 4 0.0000
668 RENAL DISORDER 2 0.0000
669 ARRHYTHMIA 2 0.0000
670 PRODUCTIVE COUGH 2 0.0000
671 BLOOD PRESSURE FLUCTUATION 1 0.0000
672 HYPOGLYCAEMIA 2 0.0000
673 CEREBRAL INFARCTION 1 0.0000
674 LIVER INJURY 1 0.0000
675 VOMITING 19 0.0000
676 DIARRHOEA 26 0.0000
677 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
678 HALLUCINATION 3 0.0000
679 CELLULITIS 2 0.0000
680 HYPOPHAGIA 1 0.0000
681 ANAPHYLACTIC SHOCK 1 0.0000
682 SKIN ULCER 1 0.0000
683 HAEMATOMA 1 0.0000
684 RESPIRATORY TRACT INFECTION 1 0.0000
685 DEAFNESS 1 0.0000
686 MUSCULOSKELETAL PAIN 2 0.0000
687 HYPERSENSITIVITY 7 0.0000
688 RENAL FAILURE 5 0.0000
689 PAIN OF SKIN 1 0.0000
690 DISTURBANCE IN ATTENTION 2 0.0000
691 OEDEMA 2 0.0000
692 LIMB INJURY 1 0.0000
693 DEMENTIA 1 0.0000
694 WOUND 1 0.0000
695 LABORATORY TEST ABNORMAL 1 0.0000
696 LACRIMATION INCREASED 1 0.0000
697 THERAPEUTIC RESPONSE DECREASED 2 0.0000
698 ILL-DEFINED DISORDER 2 0.0000
699 VISUAL IMPAIRMENT 4 0.0000
700 CYSTITIS 1 0.0000
701 DEEP VEIN THROMBOSIS 2 0.0000
702 OSTEONECROSIS 1 0.0000
703 NAUSEA 24 0.0000
704 VISUAL ACUITY REDUCED 1 0.0000
705 EXPIRED PRODUCT ADMINISTERED 1 0.0000
706 VIRAL INFECTION 1 0.0000
707 ANGER 1 0.0000
708 SINUSITIS 3 0.0000
709 GASTRIC DISORDER 1 0.0000
710 BURNING SENSATION 2 0.0000
711 DEATH 24 0.0000
712 MOBILITY DECREASED 2 0.0000
713 CRYING 1 0.0000
714 HEADACHE 17 0.0000
715 BRONCHITIS 2 0.0000
716 DYSPNOEA EXERTIONAL 1 0.0000
717 BACK PAIN 6 0.0000
718 ARTHRITIS 2 0.0000
719 CARDIAC FAILURE 2 0.0000
720 CARDIAC ARREST 2 0.0000
721 TREATMENT FAILURE 2 0.0000
722 FALL 8 0.0000
723 URTICARIA 4 0.0000
724 MENTAL DISORDER 1 0.0000
725 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
726 PULMONARY OEDEMA 1 0.0000
727 OCULAR HYPERAEMIA 1 0.0000
728 PULMONARY EMBOLISM 2 0.0000
729 RASH ERYTHEMATOUS 1 0.0000
730 BLOOD GLUCOSE DECREASED 1 0.0000
731 CONTUSION 2 0.0000
732 MALAISE 9 0.0000
733 DRY EYE 1 0.0000
734 FLUID RETENTION 1 0.0000
735 DYSPNOEA 11 0.0000
736 ILLNESS 2 0.0000
737 ECZEMA 1 0.0000
738 BRADYCARDIA 1 0.0000
739 RASH 8 0.0000
740 HAEMATOCHEZIA 1 0.0000
741 PAIN 11 0.0000
742 EYE PAIN 1 0.0000
743 CEREBROVASCULAR ACCIDENT 3 0.0000
744 ANXIETY 5 0.0000
745 EYE IRRITATION 1 0.0000
746 DYSPHONIA 1 0.0000
747 BONE PAIN 1 0.0000
748 WHEEZING 1 0.0000
749 CHEST PAIN 3 0.0000
750 EXPOSURE DURING PREGNANCY 1 0.0000
751 DIZZINESS 8 0.0000
752 LOSS OF CONSCIOUSNESS 2 0.0000
753 RHINORRHOEA 1 0.0000
754 SWELLING FACE 1 0.0000
755 DEHYDRATION 2 0.0000
756 HEPATIC ENZYME INCREASED 1 0.0000
757 ERYTHEMA 3 0.0000
758 VISION BLURRED 2 0.0000
759 MEMORY IMPAIRMENT 2 0.0000
760 HYPERTENSION 3 0.0000
761 SKIN BURNING SENSATION 1 0.0000
762 CONSTIPATION 3 0.0000
763 DYSGEUSIA 1 0.0000
764 UNEVALUABLE EVENT 1 0.0000
765 ACNE 1 0.0000
766 DEPRESSION 3 0.0000
767 FATIGUE 10 0.0000
768 DRUG INTERACTION 2 0.0000
769 GASTROINTESTINAL DISORDER 1 0.0000
770 ADVERSE EVENT 1 0.0000
771 WEIGHT DECREASED 3 0.0000
772 DRUG INTOLERANCE 1 0.0000
773 ATRIAL FIBRILLATION 1 0.0000
774 HEART RATE INCREASED 1 0.0000
775 FLUSHING 1 0.0000
776 CHEST DISCOMFORT 1 0.0000
777 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
778 ABDOMINAL DISTENSION 1 0.0000
779 INFLUENZA 1 0.0000
780 PALPITATIONS 1 0.0000
781 CHILLS 1 0.0000
782 FEELING ABNORMAL 2 0.0000
783 OEDEMA PERIPHERAL 1 0.0000
784 INSOMNIA 2 0.0000
785 ARTHRALGIA 3 0.0000
786 DRUG DOSE OMISSION 1 0.0000
787 URINARY TRACT INFECTION 1 0.0000
788 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
789 NO ADVERSE EVENT 1 0.0000
790 NASOPHARYNGITIS 1 0.0000
791 ALOPECIA 1 0.0000
792 OVERDOSE 1 0.0000
793 WEIGHT INCREASED 1 0.0000
794 PRURITUS 1 0.0000